Cell Biotech Statistics

Total Valuation

Cell Biotech has a market cap or net worth of KRW 93.56 billion. The enterprise value is 16.75 billion.

Market Cap	93.56B
Enterprise Value	16.75B

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Cell Biotech has 6.84 million shares outstanding. The number of shares has decreased by -0.26% in one year.

Shares Outstanding	6.84M
Shares Change (YoY)	-0.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.46%
Owned by Institutions (%)	9.26%
Float	4.49M

Valuation Ratios

The trailing PE ratio is 7.22.

PE Ratio	7.22
Forward PE	n/a
PS Ratio	1.73
PB Ratio	0.81
P/FCF Ratio	5.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.44, with an EV/FCF ratio of 0.95.

EV / Earnings	1.29
EV / Sales	0.31
EV / EBITDA	1.44
EV / EBIT	2.18
EV / FCF	0.95

Financial Position

The company has a current ratio of 14.55, with a Debt / Equity ratio of 0.01.

Current Ratio	14.55
Quick Ratio	13.73
Debt / Equity	0.01
Debt / EBITDA	0.11
Debt / FCF	0.08
Interest Coverage	104.90

Financial Efficiency

Return on equity (ROE) is 11.71% and return on invested capital (ROIC) is 4.35%.

Return on Equity (ROE)	11.71%
Return on Assets (ROA)	4.12%
Return on Capital (ROIC)	4.35%
Revenue Per Employee	474.54M
Profits Per Employee	113.74M
Employee Count	114
Asset Turnover	0.46
Inventory Turnover	3.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+22.82%
50-Day Moving Average	13,780.80
200-Day Moving Average	12,694.25
Relative Strength Index (RSI)	46.23
Average Volume (20 Days)	14,749

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Biotech had revenue of KRW 54.10 billion and earned 12.97 billion in profits. Earnings per share was 1,893.42.

Revenue	54.10B
Gross Profit	38.67B
Operating Income	7.78B
Pretax Income	14.14B
Net Income	12.97B
EBITDA	11.71B
EBIT	7.78B
Earnings Per Share (EPS)	1,893.42

Full Income Statement

Balance Sheet

The company has 78.14 billion in cash and 1.33 billion in debt, giving a net cash position of 76.81 billion or 11,223.01 per share.

Cash & Cash Equivalents	78.14B
Total Debt	1.33B
Net Cash	76.81B
Net Cash Per Share	11,223.01
Equity (Book Value)	115.82B
Book Value Per Share	16,922.86
Working Capital	81.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.31 billion and capital expenditures -734.47 million, giving a free cash flow of 17.57 billion.

Operating Cash Flow	18.31B
Capital Expenditures	-734.47M
Free Cash Flow	17.57B
FCF Per Share	2,567.93

Full Cash Flow Statement

Margins

Gross margin is 71.48%, with operating and profit margins of 14.38% and 23.97%.

Gross Margin	71.48%
Operating Margin	14.38%
Pretax Margin	26.14%
Profit Margin	23.97%
EBITDA Margin	21.65%
EBIT Margin	14.38%
FCF Margin	32.49%

Dividends & Yields

This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 3.29%.

Dividend Per Share	450.00
Dividend Yield	3.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.75%
Buyback Yield	0.26%
Shareholder Yield	3.55%
Earnings Yield	13.85%
FCF Yield	18.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Biotech has an Altman Z-Score of 10.05.

Altman Z-Score	10.05
Piotroski F-Score	n/a